Strategy for De-Escalating Radiation Therapy for Patients With Oropharyngeal Cancer
Posted: 03/28/2022 | By: Chase Doyle

Question 1 of 5

De-escalation of definitive radiotherapy in patients with p16-positive oropharyngeal cancer through mid-therapy FDG-PET response adaptation resulted in less acute toxicity and improved quality of life, as evidenced by which of the following outcomes?

Choose 1